EPFL Deep Brain Stimulation spin-off raises 10 million Swiss francs
August 25, 2011 By Cécilia Carron in Neuroscience
One of the biggest financing rounds for furthering the work of a doctoral student has just been completed at EPFL. The microscopic electrodes developed by André Mercanzini which are currently in clinical trials could revolutionize Deep Brain Stimulation.
The microelectrodes developed by André Mercanzini should generate a lot of interest from investors: they have the potential to reduce side-effects, the risk of complications, and cost. At a time when Deep Brain Stimulation (DBS) has an increasing number of applications such as the treatment of pain relief, epilepsy and depression the market for these products is estimated to be around 450 million Swiss francs. It should grow at about 25% each year, notes Jean-Pierre Rosat, CEO of Aleva Neurotherapeutics. The start-up, launched by the young scientist in 2008, has just completed a round of financing that raised 10 million francs, thanks to BiomedInvest AG, BB Biotech Ventures III, Initiative Capital Romandie, and private investors. Its almost certainly a record for the school for an innovative product resulting from doctoral work over the last ten years.
The DBS technique has been used since the beginning of the nineties for the treatment of Parkinsons Disease. It consists of implanting 3 millimeters long electrodes at precise points in the brain, while a pacemaker, implanted at the level of the thorax, continuously sends impulses in order to reduce symptoms. To fit the electrode in place, the target zone is identified using the technique of radiological localization. The results are spectacular: as soon as the device is implanted, trembling, rigidity and problems with movement diminish, thus improving the quality of life of the patient.
As part of his thesis with Professor Philippe Renaud, André Mercanzini now CTO of the company developed the microscopic electro-stimulators at the Center for MicroNanoTechnology, most of the work taking place in the clean room, a dust-free area. Measuring from 50 microns in diameter (the width of a hair) to a millimeter, they will enable improved precision, which in turn will limit side effects. Its dimensions will make it possible to position more than twenty of them on the surface to be treated, compared with a maximum of four using products currently on the market. This will result in an increase in the number of neurological diseases that might be treated by this method.
The fineness of these devices will also enable easier implantation and the surgical procedures will be more rapid. Moreover, the treatment of other conditions can be envisaged, in particular psychiatric illnesses, where the relevant zone is very small. The material used is a composite of polymer and metal, and this greatly reduces any risk of rejection of the implant by the patients body.
This product, currently the subject of clinical trials at CHUV, combines reliability with cost reduction. The recent investments will allow the company to increase its activity and bring the new electrode to the market.
Provided by Ecole Polytechnique Federale de Lausanne
-
Brain implant surgeries dramatically improve symptoms of debilitating condition
Mar 08, 2011 |
not rated yet |
0
-
Methodist neurosurgeon first in world to implant next generation device for deep brain stimulation therapy
Mar 16, 2011 |
not rated yet |
0
-
New approach simplifies Parkinson's surgery
May 25, 2011 |
not rated yet |
0
-
Electrode re-implantation helps some Parkinson's disease patients
May 12, 2008 |
not rated yet |
0
-
UCSF neurosurgeons test new device for placing brain implants
Apr 13, 2011 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
12 hours ago |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Neuroscience
12 hours ago |
not rated yet |
0
|
Persistent sensory experience is good for aging brain
Despite a long-held scientific belief that much of the wiring of the brain is fixed by the time of adolescence, a new study shows that changes in sensory experience can cause massive rewiring of the brain, even as one ages. ...
Neuroscience
May 24, 2012 |
not rated yet |
0
Boundary stops molecule right where it needs to be
A molecule responsible for the proper formation of a key portion of the nervous system finds its way to the proper place not because it is actively recruited, but instead because it can't go anywhere else.
Neuroscience
May 24, 2012 |
not rated yet |
0
|
Locating ground zero: How the brain's emergency workers find the disaster area
Like emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by 'eating up' any cellular debris and dead or dying neurons. ...
Neuroscience
May 24, 2012 |
5 / 5 (2) |
0
|
Genetic 'reset switch' enables signaling pathway to induce multiple developmental outcomes for olfactory neurons
Within the nervous system, a handful of signaling pathways modulate development of a cornucopia of different neuronal subtypes. Even small alterations in neuron differentiation pathways can disrupt subsequent ...
Neuroscience
May 24, 2012 |
not rated yet |
0
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...
Inherited DNA change explains overactive leukemia gene
A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.
New device allows pacemaker patients to safely undergo MRIs
For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.
Aug 25, 2011
Rank: not rated yet